Back
Milestone Pharmaceuticals Vs. Lexaria Bioscience Industry Stock Comparison
Sell
50
MIST
Milestone Pharmaceuticals
Last Price:
1.86
Seasonality Move:
-2.66%
Sell
26
LEXX
Lexaria Bioscience
Last Price:
2.14
Seasonality Move:
9.56%
Sell
50
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
- The current Milestone Pharmaceuticals [MIST] share price is $1.86. The Score for MIST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy, Sell or Hold?
- The current Lexaria Bioscience [LEXX] share price is $2.20. The Score for LEXX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- LEXX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing slight buying pressure.
LEXX Stock Price Chart
What is Lexaria Bioscience's stock price today?
-
The Lexaria Bioscience share price today is $2.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing slight selling pressure.
MIST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 64.71 | Buy |
Chaikin Money Flow: | 302912 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.44 - 1.82) | Buy |
Bollinger Bands (100): | (1.36 - 1.64) | Buy |
LEXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 38.92 | Sell |
Chaikin Money Flow: | -27130 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.14 - 2.64) | Sell |
Bollinger Bands (100): | (2.52 - 3.42) | Sell |
MIST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.8 | Buy |
20-day SMA: | 1.66 | Buy |
50-day SMA: | 1.57 | Buy |
200-day SMA: | 1.56 | Buy |
8-day EMA: | 1.78 | Buy |
20-day EMA: | 1.7 | Buy |
50-day EMA: | 1.6 | Buy |
200-day EMA: | 1.73 | Buy |
LEXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.18 | Buy |
20-day SMA: | 2.29 | Sell |
50-day SMA: | 2.78 | Sell |
200-day SMA: | 3.03 | Sell |
8-day EMA: | 2.18 | Buy |
20-day EMA: | 2.33 | Sell |
50-day EMA: | 2.64 | Sell |
200-day EMA: | 2.75 | Sell |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.20 per share.
Lexaria Bioscience Earnings Growth & LEXX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.
Milestone Pharmaceuticals Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lexaria Bioscience Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |